These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1034 related items for PubMed ID: 18282712

  • 1. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B.
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [Abstract] [Full Text] [Related]

  • 2. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Trummer G, Berchtold-Herz M, Schlensak C, Zieger B.
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
    Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M.
    Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
    [Abstract] [Full Text] [Related]

  • 5. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D.
    J Am Coll Cardiol; 2010 Oct 05; 56(15):1207-13. PubMed ID: 20598466
    [Abstract] [Full Text] [Related]

  • 6. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr 05; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 7. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Apr 05; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 8. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
    Goda M, Jacobs S, Rega F, Peerlinck K, Jacquemin M, Droogne W, Vanhaecke J, Van Cleemput J, Van den Bossche K, Meyns B.
    J Heart Lung Transplant; 2013 May 05; 32(5):539-45. PubMed ID: 23570742
    [Abstract] [Full Text] [Related]

  • 9. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
    Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N.
    Ann Thorac Surg; 2010 Oct 05; 90(4):1263-9; discussion 1269. PubMed ID: 20868825
    [Abstract] [Full Text] [Related]

  • 10. Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients.
    Joyce D, Crow S, Li Z, Joyce L, Milano C, Rogers J, Villamizar-Ortiz N, Chen D.
    J Heart Lung Transplant; 2012 Jul 05; 31(7):750-6. PubMed ID: 22538169
    [Abstract] [Full Text] [Related]

  • 11. Platelet dysfunction in outpatients with left ventricular assist devices.
    Steinlechner B, Dworschak M, Birkenberg B, Duris M, Zeidler P, Fischer H, Milosevic L, Wieselthaler G, Wolner E, Quehenberger P, Jilma B.
    Ann Thorac Surg; 2009 Jan 05; 87(1):131-7. PubMed ID: 19101285
    [Abstract] [Full Text] [Related]

  • 12. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML.
    Thromb Haemost; 2000 Sep 05; 84(3):401-9. PubMed ID: 11019962
    [Abstract] [Full Text] [Related]

  • 13. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Semin Thromb Hemost; 2005 Nov 05; 31(5):577-601. PubMed ID: 16276467
    [Abstract] [Full Text] [Related]

  • 14. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.
    Heilmann C, Trummer G, Beyersdorf F, Brehm K, Berchtold-Herz M, Schelling J, Geisen U, Zieger B.
    Eur J Cardiothorac Surg; 2017 Mar 01; 51(3):587-590. PubMed ID: 28082469
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients.
    Crow S, Milano C, Joyce L, Chen D, Arepally G, Bowles D, Thomas W, Ortiz NV.
    ASAIO J; 2010 Mar 01; 56(5):441-5. PubMed ID: 20613494
    [Abstract] [Full Text] [Related]

  • 16. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M, Kimura A, Chiba Y, Yoshida Y.
    Thromb Haemost; 1988 Jun 16; 59(3):485-90. PubMed ID: 3142084
    [Abstract] [Full Text] [Related]

  • 17. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL, Malehsa D, Budde U, Bara C, Haverich A, Strueber M.
    JACC Heart Fail; 2014 Apr 16; 2(2):141-5. PubMed ID: 24720921
    [Abstract] [Full Text] [Related]

  • 18. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Apr 16; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 19. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).
    Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2162-7. PubMed ID: 19497443
    [Abstract] [Full Text] [Related]

  • 20. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 09; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.